Evidence map›Paper›PMID 19680139›Full record

ArticleJournal of neuropathology and experimental neurology2009

Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis.

Chandra Deb, Reghann G Lafrance-Corey, Laurie Zoecklein, Louisa Papke, Moses Rodriguez, Charles L Howe

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chandra DebDepartments of Neurology, Mayo Clinic, Rochester, Minnesota.
Reghann G Lafrance-Corey
Laurie Zoecklein
Louisa Papke
Moses Rodriguez
Charles L Howe
Mayo Clinic · US

Funding

Transgenic expression of Theiler's Virus encoded regionsP01NS038468 · NINDS · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI RODRIGUEZ, MOSES · 2000 to 2004
$5.0M
T cell Function in Murine Model of Multiple SclerosisR01NS032129 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 1994 to 2010
$2.7M
IMMUNE PROMOTION OF REMYELINATIONR01NS024180 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 1987 to 2008
$2.7M
NINDS NIH HHS P01 NS038468NINDS NIH HHS P01 NS38468NINDS NIH HHS R01 NS024180NINDS NIH HHS R01 NS032129NINDS NIH HHS R01 NS24180NINDS NIH HHS R01 NS32129
6 · The paper itself

Abstract

Axon injury is a major determinant of the loss of neurological function in patients with multiple sclerosis. It is unclear, however, whether damage to axons is an obligatory consequence of demyelination or whether it is an independent process that occurs in the permissive environment of demyelinated lesions. Previous investigations into the role of CD8 T cells and perforin in the Theiler murine encephalomyelitis virus model of multiple sclerosis have used mouse strains resistant to Theiler murine encephalomyelitis virus infection. To test the role of CD8 T cells in axon injury, we established a perforin-deficient mouse model on the H-2 major histocompatibility complex background thereby removing confounding factors related to viral biology in this Theiler murine encephalomyelitis virus-susceptible strain. This permitted direct comparison of clinical and pathological parameters between perforin-competent and perforin-deficient mice. The extent of demyelination was indistinguishable between perforin-competent and perforin-deficient H-2 mice, but chronically infected perforin-deficient mice exhibited preservation of motor function and spinal axons despite the presence of spinal cord demyelination. Thus, demyelination is necessary but insufficient for axon injury in this model; the absence of perforin protects axons without impacting demyelination. These results suggest that perforin is a key mediator of axon injury and lend additional support to the hypothesis that CD8 T cells are primarily responsible for axon damage in multiple sclerosis.

Indexed as

AnimalsAxonsBrainCardiovirus InfectionsCD8-Positive T-LymphocytesDemyelinating DiseasesDisease Models, AnimalFlow CytometryGene ExpressionGene Expression ProfilingH-2 AntigensMiceMice, KnockoutMultiple SclerosisPerforinReverse Transcriptase Polymerase Chain ReactionH-2 AntigensPerforin

Identifiers

PMID19680139
PMCPMC2767116
OpenAlexW2016816703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.